Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, Portugal.
Curr Neuropharmacol. 2011 Mar;9(1):251-5. doi: 10.2174/157015911795016912.
Ketamine is a noncompetitive antagonist of the NMDA-receptors, used as a dissociative anesthetic, presently included in the category of the psychoactive substances known as "club drugs". Ketamine administration was associated with impaired working memory and increased psychopathological symptoms, but there is a lack of information regarding the effects of chronic sub-anesthetic doses. Adult Wistar rats were administered ketamine, 5 and 10 mg/kg twice daily, subcutaneously for 14 days. One week later, rats were tested in an object recognition/object location task and in the open field arena. There was altered performance in both the object recognition/location and in the open field tests by the group chronically exposed to the lower dose of ketamine. These animals displayed a decreased discrimination index (p<0.05) in the object recognition task, were unable to recognize the displacement of a familiar object and displayed decreased activity across open filed sessions. Importantly, these alterations were not observed in animals administered a higher dose of ketamine. Collectively, these results consistently show that chronic administration of ketamine in sub-anesthetic doses may lead to decreased habituation and inability to update spatial representations.
氯胺酮是非 NMDA 受体竞争性拮抗剂,用作分离麻醉剂,目前被归类为所谓的“俱乐部药物”中的精神活性物质。氯胺酮的给药与工作记忆受损和精神病理学症状增加有关,但对于慢性亚麻醉剂量的影响知之甚少。成年 Wistar 大鼠每天两次皮下给予 5 和 10mg/kg 的氯胺酮,共 14 天。一周后,大鼠在物体识别/物体定位任务和开阔场中进行测试。慢性暴露于较低剂量氯胺酮的大鼠在物体识别/位置和开阔场测试中表现出改变的表现。这些动物在物体识别任务中的辨别指数降低(p<0.05),无法识别熟悉物体的位移,并且在整个开阔场会话中的活动减少。重要的是,在给予较高剂量氯胺酮的动物中未观察到这些改变。总之,这些结果一致表明,亚麻醉剂量的氯胺酮慢性给药可能导致习惯化减少和无法更新空间表示。